ALLO vs EW · rev $22.0K vs P/E 47, rev $1.39B
Allogene Therapeutics Inc (ALLO) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported ALLO revenue for 2024-12-31 was $22.0K. Net income was -$257.6M. Revenue was down 76.8% from 2023-12-31 to 2024-12-31. ALLO currently screens at market cap $258.1M.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
ALLO currently screens at market cap $258.1M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the ALLO and EW stock pages for the full models.
Not investment advice.